Literature DB >> 22632781

Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.

José Luiz Pedroso1, Edson Bor-Seng-Shu, Andre C Felicio, Pedro Braga-Neto, Lívia A Dutra, Camila C de Aquino, Henrique B Ferraz, Gilmar F do Prado, Manoel J Teixeira, Orlando G Barsottini.   

Abstract

OBJECTIVE: Hyperechogenicity of the substantia nigra is a frequent observation on transcranial sonography in Parkinson's disease and Machado-Joseph disease patients. Additionally, restless legs syndrome is a sleep disorder that is also frequently found in both diseases. Autopsy studies have demonstrated increased SN iron content in hyperechogenic substantia nigra. Iron storage is also known to be involved in restless legs syndrome. We formally compared echogenicity of the substantia nigra with restless legs syndrome in Parkinson's disease and Machado-Joseph disease patients.
METHODS: Transcranial brain sonography was performed in a sample of Parkinson's disease and Machado-Joseph disease patients, and findings then correlated with the presence and severity of restless legs syndrome.
RESULTS: There was a continuum of substantia nigra echogenicity among groups (Parkinson's disease versus Machado-Joseph disease versus controls) and sub-groups (Parkinson's disease with and without restless legs syndrome versus Machado-Joseph disease with and without restless legs syndrome) as well as a statistically significant negative correlation between restless legs syndrome severity and substantia nigra echogenicity (p<0.001).
CONCLUSIONS: These preliminary observations demonstrate that the severity of RLS may be influenced by nigral iron load reflected by substantia nigra echogenicity in different neurodegenerative movement disorders.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22632781     DOI: 10.1016/j.jns.2012.05.015

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Substantia nigra echogenicity in hereditary ataxias with and without nigrostriatal pathology: a pilot study.

Authors:  Patricia Martínez-Sánchez; Rubén Cazorla-García; Irene Sanz-Gallego; Elisa Correas-Callero; Irene Pulido-Valdeolivas; Javier Arpa
Journal:  Cerebellum       Date:  2015-06       Impact factor: 3.847

2.  A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease.

Authors:  Marcello Moccia; Roberto Erro; Marina Picillo; Gabriella Santangelo; Emanuele Spina; Roberto Allocca; Katia Longo; Marianna Amboni; Raffaele Palladino; Roberta Assante; Sabina Pappatà; Maria Teresa Pellecchia; Paolo Barone; Carmine Vitale
Journal:  Sleep       Date:  2016-02-01       Impact factor: 5.849

Review 3.  Iron in Restless Legs Syndrome.

Authors:  Eva C Schulte; Maria Kaffe; Barbara Schormair; Juliane Winkelmann
Journal:  Mov Disord Clin Pract       Date:  2014-06-12

4.  Serum iron may not be linked with migraine.

Authors:  Ravi Gupta; Vivekananda Lahan; Deepak Goel
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383

5.  Sleep disorders in Parkinson's disease: clinical features, iron metabolism and related mechanism.

Authors:  Shu-Yang Yu; Li Sun; Zhuo Liu; Xi-Yan Huang; Li-Jun Zuo; Chen-Jie Cao; Wei Zhang; Xiao-Min Wang
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 6.  The association of Restless Legs Syndrome with hypertension and cardiovascular disease.

Authors:  Vasiliki Katsi; Themistoklis Katsimichas; Manolis S Kallistratos; Dora Tsekoura; Thomas Makris; Athanasios J Manolis; Dimitris Tousoulis; Christodoulos Stefanadis; Ioannis Kallikazaros
Journal:  Med Sci Monit       Date:  2014-04-21

7.  Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's disease.

Authors:  Edson Bor-Seng-Shu; Andre C Felicio; Pedro Braga-Neto; Ilza Rosa Batista; Wellingson Silva Paiva; Daniel Ciampi de Andrade; Manoel Jacobsen Teixeira; Luis Augusto Franco de Andrade; Orlando Graziani Povoas Barsottini; Ming Chi Shih; Rodrigo A Bressan; Henrique Ballalai Ferraz
Journal:  Med Sci Monit       Date:  2014-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.